21 Apr 2020 --- Chr. Hansen Holding has acquired Austrian B2B company HSO Health Care to bolster its position in the probiotics for women’s health space. The move strengthens and expands Chr. Hansen’s global microbial platform with the addition of HSO’s Astarte probiotic range to its portfolio. Moreover, it is aligned with its strategy of pursuing bolt-on acquisitions in the microbial platform, as outlined in its annual strategy. The transaction will be finalized later this week, and the involved parties will not be disclosing any financial details.
